CO2 laser concentrates heat on a very small area. Raised tissue is treated through measured passes.
The CO2 laser turns a thin layer of tissue into vapor through measured passes.
Heat acts on selected raised tissue while respecting landmarks near the eye.
Size, base, skin tone, and distance from lashes guide the decision.
Eyelid skin is thin and mobile. Before discussing CO2 laser, the physician checks distance from lashes, eyelid margin, and tear duct opening.
The laser targets only the selected lesion. If it touches the eyelid margin, another technique or referral may be discussed.
The skin around the lesion is also evaluated. Redness, crusting, or pigment change can appear after treatment.
CO2 laser mainly concerns small superficial lesions that are visible and away from eye structures.
Small superficial skin tag with a narrow base and clear borders.
Lesion away from lashes, the tear duct opening, and eyelid margin.
Raised tag that catches during cleaning, makeup, or blinking.
Stable skin tag, skin-colored, without bleeding or rapid growth.
Redness, small crusting, or pigment change to discuss before treatment.
Some lesions require another technique, referral, or postponement before treating the eyelid.
Suspicious lesion that bleeds, crusts, changes quickly, or causes lash loss.
Lesion against lashes, the eyelid margin, or the tear duct opening.
Need for tissue sample or analysis; excision may be discussed.
Active infection, open wound, or significant inflammation on the eyelid.
Darker skin or history of pigment marks after inflammation.
The session follows a clear sequence: examine, protect, treat in layers, then guide healing.
The base, distance from lashes, color, and recent changes are checked.
Selected tissue is treated with CO2 laser, with protection near the eye.
You receive instructions for cleaning, sun protection, makeup limits, and signs to watch.
THE CARE EXPERIENCE
Family Physician Trained at the Université de Montréal and a current member in good standing of the Collège des médecins du Québec (CMQ), Dr. Karen Dzolang serves as the medical director of the CARE network. For eyelid lesions like xanthelasma, she helps frame the assessment, possible indications, limits of removal, and situations where another medical opinion might be preferable.
